We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why IDEXX Laboratories (IDXX) is Poised to Beat Earnings Estimates (Again)
Read MoreHide Full Article
Looking for a stock that might be in a good position to beat earnings at its next report? Consider IDEXX Laboratories, Inc. (IDXX - Free Report) , a firm in the Medical Instruments industry, which could be a great candidate for another beat.
This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, IDXX has beaten estimates by at least 10% in both cases, suggesting it has a nice short-term history of crushing expectations.
Earnings in Focus
Two quarters ago, IDXX expected to post earnings of 46 cents per share, while it actually produced earnings of 51 cents per share, a beat of 10.9%. Meanwhile, for the most recent quarter, the company looked to deliver earnings of 62 cents per share, when it actually reported earnings of 80 cents per share instead, representing a 29.0% positive surprise.
Thanks in part to this history, recent estimates have been moving higher for IDEXX Laboratories. In fact, the Earnings ESP for IDXX is positive, which is a great sign of a coming beat.
After all, the Zacks Earnings ESP compares the most accurate estimate to the broad consensus, looking to find stocks that have seen big revisions as of late, suggesting that analysts have recently become more bullish on the company’s earnings prospects. This is the case for IDXX, as the firm currently has a Zacks Earnings ESP of 1.70%, so another beat could be around the corner.
This is particularly true when you consider that IDXX has a great Zacks Rank #1(Strong Buy) which can be a harbinger of outperformance and a signal for a strong earnings profile. And when you add this solid Zacks Rank to a positive Earnings ESP, a positive earnings surprise happens nearly 70% of the time, so it seems pretty likely that IDXX could see another beat at its next report, especially if recent trends are any guide.
Confidential from ZacksBeyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why IDEXX Laboratories (IDXX) is Poised to Beat Earnings Estimates (Again)
Looking for a stock that might be in a good position to beat earnings at its next report? Consider IDEXX Laboratories, Inc. (IDXX - Free Report) , a firm in the Medical Instruments industry, which could be a great candidate for another beat.
This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, IDXX has beaten estimates by at least 10% in both cases, suggesting it has a nice short-term history of crushing expectations.
Earnings in Focus
Two quarters ago, IDXX expected to post earnings of 46 cents per share, while it actually produced earnings of 51 cents per share, a beat of 10.9%. Meanwhile, for the most recent quarter, the company looked to deliver earnings of 62 cents per share, when it actually reported earnings of 80 cents per share instead, representing a 29.0% positive surprise.
IDEXX LABS INC Price and EPS Surprise
IDEXX LABS INC Price and EPS Surprise | IDEXX LABS INC Quote
Thanks in part to this history, recent estimates have been moving higher for IDEXX Laboratories. In fact, the Earnings ESP for IDXX is positive, which is a great sign of a coming beat.
After all, the Zacks Earnings ESP compares the most accurate estimate to the broad consensus, looking to find stocks that have seen big revisions as of late, suggesting that analysts have recently become more bullish on the company’s earnings prospects. This is the case for IDXX, as the firm currently has a Zacks Earnings ESP of 1.70%, so another beat could be around the corner.
This is particularly true when you consider that IDXX has a great Zacks Rank #1(Strong Buy) which can be a harbinger of outperformance and a signal for a strong earnings profile. And when you add this solid Zacks Rank to a positive Earnings ESP, a positive earnings surprise happens nearly 70% of the time, so it seems pretty likely that IDXX could see another beat at its next report, especially if recent trends are any guide.
Confidential from ZacksBeyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>